◦ Patients with epithelial ovarian cancer, including high- and low-grade serous, high- and low-grade endometrioid, mucinous (expansile and infiltrative types), and carcinosarcoma.
* FIGO 2014 stage IA-IVB.
* Patients undergoing primary surgery or interval surgery after 3-4 or 6 cycles of chemtherapy
* Patients with no residual disease after surgery.
* Patients with ECOG performance status 0-1.
You may not be if
◦ Patients without epithelial ovarian cancer.
* Patients with ECOG 2-4.
* Patients who do not consent to participate in the study.
* Patients who did not undergo complete staging surgery (including hysterectomy, bilateral salpingo-oophorectomy, pelvic and para-aortic lymphadenectomy, and omentectomy) or with residual disease after cytoreductive surgery.
Clareo Health | Anatomopathological Analysis of the Infundibulopelvic Ligament in Patients With Ovarian Cancer
